COVID-19: Pandemic Could Bring Advances In Diagnostics Development, Experts Say
The diagnostics industry could benefit from a greater focus on real-world evidence linked to the COVID-19 pandemic, according to experts from the US FDA and industry.
You may also be interested in...
An initial version of real-world data project NESTcc – the National Evaluation System for health Technology Coordinating Center – is expected to be open for business and ready to take unsolicited proposals by the end of the year.
The US Department of Justice says the company provided advertising assistance and educational grants to health care providers that used its embolization devices.
The US FDA hopes to finalize or issue draft guidance documents on about 30 topics in fiscal year 2021.